IMS Health (IMS) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
UBS Starts IMS Health Holdings (IMS) at Neutral (Earlier)
February 5, 2015 11:10 AM ESTUBS earlier initiated coverage on IMS Health Holdings (NYSE: IMS) with a Neutral rating and a price target of $27. Analyst Steven Valiquette said it was a solid company but in his view FX mutes growth near-term.
"IMS is a leader in healthcare data... More
